Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension of oxcarbazepine adjunctive therapy in children with partial-onset seizures
jRCT2080220972Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxcarbazepine in epilepsy, sponsored by Nobelpharma Co., Ltd. Started Jan 2010; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080220972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220972.